Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X:
“Frontline AML therapy is rapidly evolving with targeted and lower-intensity options. We created a quick upfront AML treatment algorithm to help guide initial therapy selection by patient fitness and disease biology.”
Other articles about AML on OncoDaily.